Actively Recruiting

Age: 18Years +
All Genders
NCT07510984

Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)

Led by Knappschaft Kliniken GmbH · Updated on 2026-04-14

721

Participants Needed

1

Research Sites

66 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to learn whether heterotopic gastric mucosa (HGM) in the upper esophagus is associated with swallowing difficulties (dysphagia) in adults undergoing a medically indicated gastroscopy. The main questions it aims to answer are: * Is the presence of HGM associated with dysphagia? * Is the presence of HGM associated with dyspepsia and reduced health-related quality of life? Among participants reporting dysphagia, what is the distribution of oropharyngeal versus esophageal dysphagia, and is this related to the presence of HGM? If there is a comparison group: Researchers will compare participants with endoscopically confirmed HGM to participants without HGM to determine whether dysphagia, dyspepsia symptoms, and quality-of-life measures differ between groups. Participants will: Complete pseudonymised questionnaires about dysphagia, dyspepsia symptoms, and quality of life before the gastroscopy. Undergo the medically indicated gastroscopy as planned; the endoscopist will assess whether HGM is present based on the endoscopic appearance, and routine endoscopy findings will be documented.

CONDITIONS

Official Title

Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Planned upper gastrointestinal endoscopy (gastroscopy) for clinical reasons (any indication)
  • Age 18 years or older
  • Written informed consent
  • Ability to complete the study questionnaires prior to endoscopy
Not Eligible

You will not qualify if you...

  • Previously known heterotopic gastric mucosa (HGM)
  • Previously diagnosed dysphagia with prior therapeutic intervention (diet modification, partial oral/enteral nutrition, steroid therapy, botulinum toxin injection, etc.)
  • Mechanical ventilation
  • Presence of a tracheostomy
  • Inadequate endoscopic assessability of the proximal esophagus (poor general condition, increased aspiration risk, poor visibility, complications preventing careful inspection)
  • History of surgery involving the pharynx or esophagus
  • Relevant severe neurological disorder (e.g., ALS, stroke)
  • Severe dementia
  • Severe depressive disorder
  • Lack of cooperation or inability to comply with study procedures
  • Planned PEG placement
  • Emergency endoscopy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Knappschaftskrankenhaus Bottrop

Bottrop, North Rhine-Westphalia, Germany, 46240

Actively Recruiting

Loading map...

Research Team

F

Felix Horstmann, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here